Arkolith/Insider Trading/TCRX/Form 4

Klencke Barbara

DirectorTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Aug 27, 2024
Net Buying
Open-Market Buys
$56K
Open-Market Sells
$0
Net Open-Market Flow
$56K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2024Buy(P)5K$5.53$28K40K
Aug 23, 2024Buy(P)5K$5.69$28K35K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-101166) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML